TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of TetraLogic Pharmaceuticals Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. TetraLogic Pharmaceuticals Corp market cap is $4,900.00.
What is the 52-week high for TetraLogic Pharmaceuticals Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. TetraLogic Pharmaceuticals Corp 52 week high is $0.001 as of September 17, 2025.
What is the 52-week low for TetraLogic Pharmaceuticals Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. TetraLogic Pharmaceuticals Corp 52 week low is $0.00 as of September 17, 2025.
What is TetraLogic Pharmaceuticals Corp stock price today?
TetraLogic Pharmaceuticals Corp stock price today is $0.0002.
What was TetraLogic Pharmaceuticals Corp stock price yesterday?
TetraLogic Pharmaceuticals Corp stock price yesterday was $0.001.
What is the 50-day moving average of TetraLogic Pharmaceuticals Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. TetraLogic Pharmaceuticals Corp 50-day moving average is $0.0002.
